Dr. Gregory Bunt graduated medical school in 1983 from NYU School of Medicine, and completed his residency in Psychiatry at the Albert Einstein College of Medicine in 1987.
He was among the first to complete the Fellowship in Addiction Psychiatry at NYU School of Medicine (1989), and has since been on the NYU Medical School Faculty in the Division of Alcoholism and Drug Abuse, currently as an Assistant Clinical Professor of Psychiatry. He is a diplomat of the American Board of Psychiatry and Neurology with Special Added Qualifications in Addiction Psychiatry.
Dr. Bunt is the Immediate Past President of the New York Society of Addiction Medicine and currently the President of the International Society of Addiction Medicine. He has been the Medical Director for Daytop Village and Daytop International for 25 years. He has authored over a dozen publications and speaks nationally and internationally about addiction medicine and therapeutic communities.
Dr. el-Guebaly’s introduction to mental health and addiction medicine dates back to 1969 during initial psychiatric training in the United Kingdom, followed by training in Canada and the United States
Addiction related work includes being the current Professor and Head of Division of Addiction, Department of Psychiatry at the University of Calgary, and the founding past Medical Director of the Calgary Health Region Addiction Centre and Program. Dr. el-Guebaly was the Founding Past President of the International Society of Addiction Medicine, its Executive Medical Director for another 6 years, and currently Chief Examiner of the International Certification Examination and Senior Editor of the recent Textbook of Addiction Treatment: International Perspectives (Springer 2015).
Dr. el-Guebaly completed three 3-year terms as Board Chair of the Alberta Gaming Research Institute, and is now the Alberta Gambling Research Institute’s current Research Director as well as Editor in Chief of the Canadian Journal of Addiction for the last 4 years. These interests have resulted in 260 peer-reviewed papers, 80 chapters, 568 presentations, and 60 past and current grants totaling $7 million.
He is a member, of Alberta’s Responsible Gambling Advisory Committee, the Royal College Addiction Medicine Specialty Committee, the Provincial Addiction Curricula and Experiential Skills Training for Alberta Health Services, and the CSAM Conference committee.
Marc Galanter, M.D. is a Professor of Psychiatry at NYU. He has served as a Clinical Associate at the U.S. National Institute of Mental Health; as President of the Association for Medical Education and Research in Substance Abuse, the American Academy of Addiction Psychiatry, and the American Society of Addiction Medicine; and as Chief Editor of the International Society of Addiction Medicine.
He founded the Division of Alcoholism and Drug Abuse at NYU and the journal “Substance Abuse;” is co-editor of the American Psychiatric Association’s “Textbook of Substance Abuse Treatment,” and has published over 200 peer-reviewed articles, addressing pharmacologic and psychosocial treatment for addiction, and the psychology of Twelve-Step recovery.
He has received the Gold Achievement Award for innovation in treatment and the Seymour Vestermark Award for psychiatric education from the American Psychiatric Association; the Smithers Distinguished Scientist Award from ASAM; and New York State’s Award for Psychiatric Research.
Shalini is a consultant addiction psychiatrist and clinician researcher. She is Deputy Clinical Director at Turning Point, an Australian national addiction treatment and research centre; and Deputy Head and Senior Lecturer at the Department of Psychiatry at Central Clinical School, Monash University. Shalini is Chair of the RANZCP Binational Faculty of Addiction Psychiatry, the peak body for psychiatrists across Australia and New Zealand.
Her clinical and research interests include methamphetamine use and mental health problems, and women’s health and addictive disorders. She is an investigator on multiple Australian clinical trials of medication treatments for addiction, including DEBUT, N-ICE and LiMA.
Regional Representative - Africa & Eastern Mediterranean
Prof. Gawad is currently holding positions as Director of Treatment and Rehabilitation at the National rehabilitation centre of Abu Dhabi UAE. He is Professor of Psychiatry, Cairo University, Cairo Egypt.
He was graduated in 1981 from Faculty of Medicine Cairo University where he received his M.B. BCh ; Master degree in Psychological Medicine and Neurology (1985) ; MD Psychiatry (1991) and Diploma in Addiction Behaviour – Institute of Psychiatry, London University (1987) .
Since his graduation he was appointed as staff member at the department of Psychiatry Faculty of Medicine Cairo university where he is still holding his position as professor since 2001.
He served as the Past President of the International Society of Addiction Medicine (ISAM), the past Chair of the World Psychiatric Association Section of Addiction Psychiatry (WPA).
He participated and published numerous research covering most of psychiatric subjects notably in addiction. His primarily interested in comorbidy studies and developing addiction psychiatric services. He is the Co-PI of the Fogarty grant od Addiction Research between Cairo university and UCLA since 2012.
His goal is to achieve well-established scientifically-based centres in Drug Addiction with a suitable network both nationally and internationally.